Novo Nordisk A/S reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was DKK 42,031 million compared to DKK 33,804 million a year ago. Net income was DKK 14,210 million compared to DKK 12,623 million a year ago. Basic earnings per share from continuing operations was DKK 6.24 compared to DKK 5.47 a year ago. Diluted earnings per share from continuing operations was DKK 6.22 compared to DKK 5.45 a year ago.